Company Analysis

Rani Therapeutics Holdings, Inc. (RANI)

Nasdaq: RANI · Pharmaceutical Preparations · San Jose, CA · filing with the SEC since 2021
Grade3.8
◀ Past 3.3● Present 3.2▶ Future 4.5
3 est.

Who runs Rani Therapeutics Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Imran Talat
Chief Executive Officer. First filing Jul 2021, latest Sep 29, 2026, 7 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
18 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Imran TalatChief Executive OfficerJul 2021Sep 29, 2026none
Javadi AlirezaChief Technical OfficerMar 2026Sep 29, 20261 · $0.00
Maestas NicholasChief Financial OfficerJul 2026Jul 21, 2026none
Mckinley KateChief Business OfficerAug 2023Jun 5, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Gilson MichelledirectorAug 2026Aug 4, 2026none
Imran Mir AdirectorJul 2021Jul 23, 2026none
Ausiello Dennis AdirectorJul 2021Jun 1, 2026none
Bailey Vasudev JaiprakashdirectorOct 2025Jun 1, 2026none
Bassan AbrahamdirectorOct 2025Jun 1, 2026none
Butel Jean LucdirectorJul 2021Jun 1, 2026none
Rometty Lisa AnndirectorJan 2022Jun 1, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
South Cone Investments Limited Partnership10% ownerJul 2021Oct 22, 20252 · $15.7M
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton RANI · research, not advice